Simone Filosto

3.5k total citations
35 papers, 880 citations indexed

About

Simone Filosto is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Simone Filosto has authored 35 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Simone Filosto's work include CAR-T cell therapy research (17 papers), Sphingolipid Metabolism and Signaling (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Simone Filosto is often cited by papers focused on CAR-T cell therapy research (17 papers), Sphingolipid Metabolism and Signaling (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Simone Filosto collaborates with scholars based in United States, France and Italy. Simone Filosto's co-authors include Tzipora Goldkorn, Samuel Chung, Antonio Marrazzo, Vittorio Gebbia, Sebastiano Mercadante, Maria Carmela Roccheri, William Fry, Elaine M. Khan, Anne A. Knowlton and Maria Agnello and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Simone Filosto

32 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Filosto United States 15 369 252 179 115 92 35 880
Wenjing Xu China 12 289 0.8× 181 0.7× 103 0.6× 150 1.3× 92 1.0× 22 783
Xi Huang China 17 340 0.9× 199 0.8× 74 0.4× 102 0.9× 30 0.3× 45 711
Dongmei Wu China 12 253 0.7× 155 0.6× 76 0.4× 135 1.2× 33 0.4× 24 692
Hui Lin Chua United States 19 494 1.3× 394 1.6× 259 1.4× 104 0.9× 78 0.8× 29 1.3k
Koki Kabu Japan 11 363 1.0× 138 0.5× 84 0.5× 60 0.5× 125 1.4× 22 1.1k
Gloria Ravegnini Italy 22 427 1.2× 194 0.8× 333 1.9× 131 1.1× 47 0.5× 87 1.4k
Joel Mefford United States 15 282 0.8× 231 0.9× 126 0.7× 83 0.7× 41 0.4× 35 767
Wen‐Yang Hu United States 19 472 1.3× 95 0.4× 180 1.0× 173 1.5× 51 0.6× 44 1.2k

Countries citing papers authored by Simone Filosto

Since Specialization
Citations

This map shows the geographic impact of Simone Filosto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Filosto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Filosto more than expected).

Fields of papers citing papers by Simone Filosto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Filosto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Filosto. The network helps show where Simone Filosto may publish in the future.

Co-authorship network of co-authors of Simone Filosto

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Filosto. A scholar is included among the top collaborators of Simone Filosto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Filosto. Simone Filosto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Locke, Frederick L., Nathalie Scholler, Mike Mattie, et al.. (2025). Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma. Clinical Cancer Research. 31(18). 3834–3843.
2.
Nayak, Lakshmi, Ugonma Chukwueke, Christopher Meehan, et al.. (2024). A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL).. Journal of Clinical Oncology. 42(16_suppl). 2006–2006. 9 indexed citations
4.
Locke, Frederick L., Olalekan O. Oluwole, John Kuruvilla, et al.. (2024). Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume. Blood. 143(24). 2464–2473. 14 indexed citations
5.
Filosto, Simone, Manoj Chiney, Francesca Milletti, et al.. (2024). Investigating the Influence of Covariates on Axicabtagene Ciloleucel (axi-cel) Kinetics in Patients with Non-Hodgkin’s Lymphoma. Clinical Pharmacokinetics. 63(9). 1283–1299. 2 indexed citations
6.
Filosto, Simone, Saran Vardhanabhuti, Miguel Canales, et al.. (2023). Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7). Blood Cancer Discovery. 5(1). 21–33. 18 indexed citations
7.
Jain, Michael D., David B. Miklos, Caron A. Jacobson, et al.. (2023). Axicabtagene Ciloleucel in Combination with the 4–1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11. Clinical Cancer Research. 29(20). 4118–4127. 6 indexed citations
8.
9.
Miles, Brodie, Saran Vardhanabhuti, Christina To, et al.. (2023). Circulating tumor DNA (ctDNA) by clonoSEQ to monitor residual disease after axicabtagene ciloleucel (axi-cel) in large B-cell lymphoma (LBCL).. Journal of Clinical Oncology. 41(16_suppl). 7547–7547. 2 indexed citations
11.
12.
Chung, Samuel, Simon Vu, Simone Filosto, & Tzipora Goldkorn. (2014). Src Regulates Cigarette Smoke–Induced Ceramide Generation via Neutral Sphingomyelinase 2 in the Airway Epithelium. American Journal of Respiratory Cell and Molecular Biology. 52(6). 738–748. 18 indexed citations
13.
Filosto, Simone, et al.. (2013). Src Mediates Cigarette Smoke–Induced Resistance to Tyrosine Kinase Inhibitors in NSCLC Cells. Molecular Cancer Therapeutics. 12(8). 1579–1590. 27 indexed citations
14.
Filosto, Simone, et al.. (2012). Cigarette Smoke Induces Aberrant EGF Receptor Activation That Mediates Lung Cancer Development and Resistance to Tyrosine Kinase Inhibitors. Molecular Cancer Therapeutics. 11(4). 795–804. 70 indexed citations
15.
Filosto, Simone, et al.. (2011). Neutral Sphingomyelinase 2 Activity and Protein Stability Are Modulated by Phosphorylation of Five Conserved Serines. Journal of Biological Chemistry. 287(1). 514–522. 32 indexed citations
16.
Filosto, Simone, William Fry, Anne A. Knowlton, & Tzipora Goldkorn. (2010). Neutral Sphingomyelinase 2 (nSMase2) Is a Phosphoprotein Regulated by Calcineurin (PP2B). Journal of Biological Chemistry. 285(14). 10213–10222. 53 indexed citations
17.
Filosto, Simone, Lisa Franzi, Elaine M. Khan, et al.. (2010). Neutral Sphingomyelinase 2. American Journal of Respiratory Cell and Molecular Biology. 44(3). 350–360. 71 indexed citations
18.
Filosto, Simone, Maria Carmela Roccheri, Rosa Bonaventura, & Valeria Matranga. (2008). Environmentally relevant cadmium concentrations affect development and induce apoptosis of Paracentrotus lividus larvae cultured in vitro. Cell Biology and Toxicology. 24(6). 603–610. 44 indexed citations
19.
Agnello, Maria, Simone Filosto, Rosaria Scudiero, Anna Maria Rinaldi, & Maria Carmela Roccheri. (2007). Cadmium induces an apoptotic response in sea urchin embryos. Cell Stress and Chaperones. 12(1). 44–44. 42 indexed citations
20.
Agnello, Maria, Simone Filosto, Rosaria Scudiero, Anna Maria Rinaldi, & Maria Carmela Roccheri. (2006). Cadmium accumulation induces apoptosis in P. Lividus em- bryos. Caryologia. 407–412. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026